Diffusion Pharmaceuticals Inc. is an innovative biopharmaceutical company developing novel therapies that enhance the body’s ability to deliver oxygen to the areas where it is needed most. Founded in 2001, our mission is to enhance the standard-of-care treatment for conditions associated with hypoxia, a potentially fatal shortage of oxygen in tissue and a serious complication of many of medicine’s most intractable and difficult-to-treat conditions. Our lead product candidate, Trans sodium crocetinate (TSC), is a first-in-class, small molecule therapeutic with a novel mechanism-of The company is applying its technology and its deep understanding of hypoxia to develop an intervention that may help save the lives of thousands of patients suffering from COVID-19 and other serious conditions. Lead drug trans sodium crocetinate (TSC), a first-in-class small molecule, directly targets and relieves oxygen-deprivation in affected tissue by enhancing oxygen diffusion through the blood and into the cells. Because the approach facilitates the passage of existing oxygen, rather than relying on an additional oxygen supply, it avoids the toxic side-effects of oxygen oversupply. Please beware of scams from individuals, organizations and Internet sites claiming to represent Diffusion in recruitment activities. Learn More: https://www.diffusionpharma.com/recruitment-fraud/ Terms Of Use: https://bit.ly/3FV97uj
View Top Employees from Diffusion PharmaceuticalsWebsite | http://www.diffusionpharma.com |
Ticker | DFFN |
Revenue | $3 million |
Funding | $47.7 million |
Employees | 13 (9 on RocketReach) |
Founded | 2001 |
Address | 300 East Main Street Suite 201, Charlottesville, Virginia 22902, US |
Phone | (434) 220-0718 |
Fax | (434) 220-0722 |
Technologies |
JavaScript,
HTML,
PHP
+25 more
(view full list)
|
Industry | Biotechnology, Pharmaceuticals, Pharmaceutical Manufacturing, Healthcare, Science and Engineering, Health Care, Therapeutics |
Web Rank | 8 Million |
Keywords | Diffusion Pharmaceuticals Inc, Clet Niyikiza, Diffusion Pharma Stock, Diffusion Pharmaceuticals |
Competitors | CrystalGenomics, Inc., MediciNova, Inc., Milestone Pharmaceuticals, Inc., Neuronascent, Inc, Vidac Pharma |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325413 Companies, NAICS Code 325 Companies |
Looking for a particular Diffusion Pharmaceuticals employee's phone or email?
The Diffusion Pharmaceuticals annual revenue was $3 million in 2024.
William Hornung is the CFO of Diffusion Pharmaceuticals.
9 people are employed at Diffusion Pharmaceuticals.
Diffusion Pharmaceuticals is based in Charlottesville, Virginia.
The NAICS codes for Diffusion Pharmaceuticals are [32, 3254, 32541, 325413, 325].
The SIC codes for Diffusion Pharmaceuticals are [283, 28].